SECsense Logo

NeuroOne Medical Technologies 8-K Report: Key Updates for Investors

$NMTC
Form 8-K
Filed on: 2025-01-14
Source
NeuroOne Medical Technologies 8-K Report: Key Updates for Investors

From the provided section of the financial report, here are the key pieces of information extracted:

  1. Company Identification:
  • Name: NeuroOne Medical Technologies Corporation
  • CIK: 0001500198
  • IRS Employer Identification Number (EIN): 27-0863354
  • Primary Business Address: 7599 Anagram Dr., Eden Prairie, MN 55344
  • Phone Number: 952-426-1383
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: January 14, 2025
  • SEC File Number: 001-40439
  1. Stock Information:
  • Stock Ticker Symbol: NMTC
  • Exchange: NASDAQ
  • Common Stock Par Value: $0.001 per share
  1. Period of Report:
  • Report Date: January 14, 2025
  • Context ID: AsOf2025-01-14
  1. Units of Measurement:
  • Currency: USD (U.S. Dollars)
  • Shares: Measure of company common stock.

Insights:

  • The report suggests that NeuroOne Medical Technologies Corporation is actively filing with the SEC, which is typical for public companies. The most recent filing is an 8-K, indicating that there may have been a significant event or development that warranted disclosure.
  • The company operates under a relatively low par value for its common stock, which could indicate growth potential or a strategic decision for capital raising.
  • The information provided does not contain financial performance metrics or significant operational details, which are typically crucial for assessing the company’s financial health and future prospects.
  • The context surrounding the filing (8-K) often pertains to material events, so stakeholders should review the complete filing to understand the nature of the disclosures made on this date.

For a more comprehensive analysis, additional details from the full filing would be required, particularly any financial statements or explanations of significant events that may impact investors' perceptions.